AntonioSTorloniMDMS

Pathology • Gilbert, AZ

Blood Banking & Transfusion Medicine, Transplantation Immunology, Clinical Pathology, Clinical Informatics

Medical Director, Transfusion Medicine, Apheresis, Director, Stem Cell Laboratory

Join to view full profile

Dr. Torloni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Torloni's full profile

Already have an account?

Office
MD Anderson Cancer Center - Arizona
2946 E. Banner Gateway Drive
Gilbert, AZ 85234
Phone+1 480-299-9984

Summary

Dr. Antonio "Sergio" Torloni is a double board certified pathologist at Banner MD Anderson Cancer Center , AZ. He received his medical degree from University of Brasilia Medical School and an M.S. degree in Advanced Cell Therapy and Regenerative Medicine from the University of Barcelona . He has been in practice 30 years. He specializes in Apheresis, Blood banking & Transfusion Medicine, Transplantation immunology, and General Clinical Pathology with special interest in coagulation and a passion for teaching and computer animation i medicine.
He is Director of the Stem Cell Laboratory, Blood Bank and Therapeutic Apheresis at MD Anderson Cancer Center in Phoenix Arizona. . He has authored several peer reviewed papers, been Editor of several book chapters, and co-editor of several publications including FACT standards. and is well known lecturer nationally and internationally. I currently participate in CAR-T therapy in several clinical trials. He has been a FACT inspector for 20 years.
Speaks fluently and writes in French, Spanish and Portuguese besides English
Worked as an interpreter for NASA and worked on DOD / NASA grants
Am available for online or on-site presentations at student, physician, post doctoral level. Am also interested in mentoring at all levels, especially Masters.

Education & Training

UNIVERSIDAD AUTONOMA DE BARCELONA MASTER IN SCIENCE, ADVANCED CELL THERAPY, REGENERATIVE MEDICINE , 2017 - 2019
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Blood Banking/Transfusion Medicine, 1989 - 1990
SSM Health/Saint Louis University School of MedicineResidency, Pathology-Anatomic and Clinical, 1985 - 1989
Phoenix Children's HospitalResidency, Pediatrics, 1983 - 1985
Washington Hospital CenterResidency, Pathology-Anatomic and Clinical, 1982 - 1983
University of Brasilia Foundation Faculty of MedicineClass of 1980

Certifications & Licensure

CA State Medical License 1995 - Present
AZ State Medical License 2003 - 2026
VA State Medical License 1985 - 2004
AL State Medical License 1995 - 1996
MN State Medical License 1989 - 1990
American Board of Pathology Clinical Pathology
American Board of Pathology Blood Banking/Transfusion Medicine

Awards, Honors, & Recognition

Lecturer Award American Society for Apheresis, 2010
Educator Award University Of Kentucky School of Medicine (offered by Students), 1994
Suma cum Laude, Medical School University of Brasilia School of Medicine., 1980

Clinical Trials

Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma Start of enrollment: 2008 Nov 01
Completed
Phase 1, Phase 2
Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies Start of enrollment: 2009 Aug 01
Completed
Phase 2
Study Evaluating the Efficacy and Safety of JCAR015 in Adult B-cell Acute Lymphoblastic Leukemia (B-ALL) Start of enrollment: 2015 Aug 21
Terminated
Phase 2
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001) Start of enrollment: 2016 Jan 06
Active, not recruiting
Phase 1
Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma Start of enrollment: 2016 Aug 01
Completed
Phase 1
Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product Start of enrollment: 2016 Oct 01
Terminated
Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers Start of enrollment: 2017 Dec 27
Terminated
Phase 1
Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma Start of enrollment: 2017 Oct 04
Terminated
Phase 1
Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2018 Feb 22
Terminated
Phase 1
Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2017 Oct 20
Terminated
Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Start of enrollment: 2017 Nov 27
Recruiting
Phase 1, Phase 2
Study Evaluating the Safety and Efficacy of JCARH125 in Subjects With Relapsed and/or Refractory Multiple Myeloma Start of enrollment: 2018 Feb 01
Completed
Phase 1, Phase 2
Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product Start of enrollment: 2018 Feb 19
Terminated
Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers Start of enrollment: 2019 Mar 13
Terminated
Phase 1
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007) Start of enrollment: 2018 Nov 29
Completed
Phase 2
Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers Start of enrollment: 2019 Apr 30
Terminated
Phase 1
Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma Start of enrollment: 2020 May 26
Terminated
Phase 1
Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis Start of enrollment: 2018 Aug 01
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

42 citations
Use of plasma exchange in patients with heparin-induced thrombocytopenia: a report of two cases and a review of the literature.
Elizabeth A. Jaben, A. Sergio Torloni, Rajiv K. Pruthi, Jeffrey L. Winters
Journal of Clinical Apheresis. 2011-01-01
106 citations
Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma
H. Paripati, Alexander Keith Stewart, S Cabou, Amylou C. Dueck, Victor J Jimenez Zepeda
Leukemia. 2008-01-24
10 citations
Allogeneic epidural blood patch in the setting of persistent spinal headache and disseminated coccidioidomycosis.
Terrence L. Trentman, Joseph M. Hoxworth, Shimon Kusne, A. Sergio Torloni, Naresh P. Patel
Pain Physician. 2009-05-01

Books/Book Chapters

MAny publications including W.H.O. Africa Initiative, Computer Based learning
Chapter: Introduction to Blood Bank
Torloni A (Unable to list all publications in this program)W.H.O. Press, Geneva 1996

Abstracts/Posters

Decreasing the use of pre-operative autologous blood donation for orthopedic surgery: one hospital's successful approach.
Jaben EA, Su L, Hernandez JS, Torloni A, Transfusion, 1/1/2012
Minimizing the cost of current ineffective mobilizations: doubling filgrastim on day 4 of filgrastim-alone mobilization for autologous peripheral stem cell collection ...
Betcher JA, Torloni AS, Befort CK, Slack JL, Leis JF, Adams RH, Mikhael JR, Biol Blood Marrow Transplant, 1/1/2011
Impact of lenalidomide therapy on stem call mobilization in myeloma.
Paripati H, Stewart AK, Fonseca R, Dueck AC, Slack JL, Reeder CB, Leis J, Bergasagel PL, Torloni AS, J Clin Oncol, 1/1/2008
Extended storage of liquid peripheral blood progenitor cells, prior to cryopreservation, does not affect long term disease-free survival rates (Abstract SP53).
Israel DS, Hunt SM, Rodriguez F, Torloni AS, Kitchen K, Wiltbank T, Transfusion, 1/1/2006
Evaluation of autologous peripheral CD34+ cell dose using ideal of actual body weight (Abstract P-528).
Gonzalez CTG, Zubair A, Gastineau D, Beveridge R, Winters J, Adams H, Slack J, Maningo-Salinas J, Befort C, Nolot B, Torloni A, Vox Sang, 1/1/2006
Plasmapheresis during ECMO.
Torloni AS, Lamadue JL, American Society for Apheresis Plenary Session, 1/1/2003
Thrombotic events in rhematoid arthritis patients undergoing prosorba plasma perfusion-Case reports
Lumadue JL, Torloni AS, J Clin Apheresis; American Society for Apheresis, Plenary presentations, 1/1/2002
TTP-like syndrome in a patient with systemic anthrax
Torloni AS, Lumadue JL, Roseberg J, Apheresis; American Society for Apheresis, Plenary presentations, 1/1/2002
The effect of IVIG on anti-PLA-1 during pregnancy
Smalley VS, Torloni AS, Transfusion; American Association of Blood Banks Annual Meeting, 1/1/2000
Successful treatment of remitting-relapsing multiple sclerosis by plasmarpheresis
Torloni AS, Mishra B, Transfusion; American Association of Blood Banks Annual Meeting, 1/1/2000
Use of dipstick method as an adjuvant to detection of bacterial contamination of platelets
Hutchins E, Torloni AS, Smalley VS, Transfusion; American Association of Blood Banks Annual Meeting, 1/1/2000
TTP with concurrent bowel ischemia: report of two cases
Pastore L, Torloni AS, Davitt C, Clay T, Plewaki K, Transfusion; American Association of Blood Banks Annual Meeting, 1/1/1999
Improved efficacy of CD34 collection by very large volume (VLV) processing and fine tuning of collect rate.
Plewacki K, Torloni AS, Clay T, Davitt C, California Transfusion, 1/1/1999
Mild HDN due to maternal warm autoantibody
Torloni AS, Fehrle W, Bloun G, Vox Sanguinis; 48th ISBT Meeting B, Oslo, Norway, 1/1/1998
Severe autoimmune hemolytic anemia refractory to therapy
Ferhle W, Torloni AS, Blount G, Vox Sanguinis; 48th ISBT Meeting B, Oslo, Norway, 1/1/1998
Microwave vs. ultrasonic elutions, comparison of two unusual methods
Yu G, Torloni AS, Sloane T, Vox Sanguinis; Biannual meeting, Amsterdam, The Netherlands, 1/1/1994
The effect of hibernation induction trigger on metabolites of packed red blood cells during storage (Abstract S46).
Winters JL, Torloni AS, Samayoa L, Ottgen P, Talkington S, Slone T, Transfusion (Paris), 1/1/1994
Microwave dissociation of antigens-antibodies complexes from red blood cells: a new method for phenotyping red blood cells (Abstract S46).
McCullough SJ, Torloni AS, Brecher MB, Tribble L, Hill M, Transfusion (Paris), 1/1/1992
Accumulation of WBC/platelet metabolites: effect of prestorage versus poststorage leukocyte depletion (Abstract S56).
Harbaugh C, Brecher MB, Torloni AS, Pineda A, Moore SB, Transfusion (Paris), 1/1/1991
Nephelometric quantization of fetal hemoglobin.
Alexander R, Torloni AS, Clin Chem, 1/1/1989
Join now to see all

Lectures

Therapeutic Apheresis
1/1/2015
Approaches to Peripheral Blood Stem Cell Collections
Buenos Aires, Argentina - 1/1/2015
What is new in apheresis technology?
Buenos Aires, Argentina - 1/1/2015
Therapeutic Apheresis in MS & NMO, The Mayo Clinic Experience
Istanbul, Turkey - 1/1/2013
Granulocyte Transfusions
Florianopolis, SC, Brazil - 1/1/2012
Apheresis Emergencies
Florianopolis, SC, Brazil - 1/1/2012
Extracorporeal Photopheresis How does it work?
Florianopolis, SC, Brazil - 1/1/2012
Plasmapheresis for MS and other CNS Demyelinating Diseases
1/1/2011
Plasmapheresis for MS/Neuromyelitis Optica
1/1/2011
Blood Transfusion Strategy and Alternatives
Scottsdale, AZ - 1/1/2011
When Things Go Wrong
Charlottesville, VA - 1/1/2011
Introduction to Coagulation
1/1/2010
An Overview of Coagulation
1/1/2010
Peripheral Blood Stem Cell Collection in Patients Heavily Treated: Strategy for Mobilization and Collection Hemo 2010
Brasillia, Brazil - 1/1/2010
Leukopheresis Hemo 2010
Brasillia, Brazil - 1/1/2010
Granulocyte Transfusion: Myths and Realities in the 21st Century Hemo 2010
Brasillia, Brazil - 1/1/2010
Platelet Crossmatching: When and Why
Brasilia, Brazil - 1/1/2010
Granulocyte Transfusions: An Update
Brasilia, Brazil - 1/1/2010
Biological Adhesives: Where are We?
Florianopolis, Brazil - 1/1/2009
Apheresis in Thrombocytosis
1/1/2009
Apheresis in MS/NMO
San Antonio, TX - 1/1/2009
Therapeutic Leukapheresis
Richmond, VA - 1/1/2009
PBSCC Opposing Methods
1/1/2008
Photopheresis and Aquapheresis
1/1/2008
Selective Column Absorption Technology, Where Are We?
National Cancer Institute, Rio de Janeiro, Brazil - 1/1/2007
Join now to see all

Committees

Member, ABHH (Brazilan Association of Hematology and Hemotherapy) Education Committee 2018 - 2020
Vice President., International Society for Apheresis 2014 - 2017
Member, FACT 6th Edition Cord Cell Standards 2014 - 2015
Member, FACT Accreditation Committee 2013 - 2018
Chairman, International Society for Apheresis (ISFA) Education Committee 2009 - 2023
Chairman, ASFA Education Committee 2009 - 2012
Editorial Board Member., Aphresis and Dialysis 2008 - 2023
Member., AABB international Committee 2003 - 2005